Pathfinder Therapeutics' Series C - II Round

Pathfinder Therapeutics raised a round of funding on June 21, 2013.

Pathfinder Therapeutics (PTI) is the developer of Explorer, an image-guided "GPS" device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resect…

Articles about Pathfinder Therapeutics' Series C - II Round: